Stress Inoculation Training for Stress

N/A

Waitlist Available

Led By Sarah Jackson, MFT, PhD

Research Sponsored by The University of Texas Health Science Center, Houston

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Must not have

Currently undergoing another form of treatment other than supportive therapy (>2 times per month)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, about 3 weeks from baseline, about 6 weeks form baseline, about 11 weeks form baseline, end of study (an average of 19 weeks form baseline)

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to see if adding a specific training protocol, called SIT Core Protocol, to traditional Navy military training is feasible and effective. The study will look at how well the new training is implemented

Who is the study for?

This trial is for US Navy service members who are fluent in English, can give informed consent, have access to a smartphone or computer, and agree to undergo testing throughout the study. They must be available for the entire study duration but with flexibility for military demands.

What is being tested?

The trial tests Stress Inoculation Training (SIT) added to traditional Navy training. It measures how well SIT improves stress tolerance, psychological health, resilience, and job performance compared to standard training among Sailors in DCA Firefighting Training.

What are the potential side effects?

Since this trial involves psychological training rather than medication, side effects may include discomfort during stress exposure exercises or emotional distress related to confronting stressful scenarios as part of the training.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am not receiving any treatment more than twice a month, except for supportive care.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, about 3 weeks from baseline, about 6 weeks form baseline, about 11 weeks form baseline, end of study (an average of 19 weeks form baseline)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, about 3 weeks from baseline, about 6 weeks form baseline, about 11 weeks form baseline, end of study (an average of 19 weeks form baseline)

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, about 3 weeks from baseline, about 6 weeks form baseline, about 11 weeks form baseline, end of study (an average of 19 weeks form baseline) for reporting.